Proteome Sciences plc (LON:PRM – Get Free Report)’s share price shot up 10.7% during mid-day trading on Monday . The company traded as high as GBX 3.91 ($0.05) and last traded at GBX 3.40 ($0.04). 966,870 shares traded hands during trading, an increase of 496% from the average session volume of 162,145 shares. The stock had previously closed at GBX 3.07 ($0.04).
Proteome Sciences Stock Performance
The company’s 50-day moving average price is GBX 2.71 and its 200 day moving average price is GBX 3.16. The stock has a market capitalization of £9.89 million, a PE ratio of -335.00 and a beta of 0.07.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Articles
- Five stocks we like better than Proteome Sciences
- There Are Different Types of Stock To Invest In
- 3 Big-Name Stocks Just Announced Big-Time Dividend Increases
- How to Invest in the FAANG Stocks
- Time to Board Carnival Cruise Lines’ Stock Price Rally
- The Significance of Brokerage Rankings in Stock Selection
- Is Warner Bros. Discovery Stock a Buy After Recent Drop?
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
